Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

658
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
658
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

740
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
740
Pneumothorax-II01:27

Pneumothorax-II

601
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
601
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

612
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
612
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

127
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
127
Pneumothorax-I01:26

Pneumothorax-I

761
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
761

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Video-assisted thoracoscopy with pleurodesis as treatment of amiodarone induced recurrent pleural effusion.

Respiratory medicine case reports·2026
Same author

Clinical Trial Eligibility in Pulmonary Arterial Hypertension: Why Is It So Challenging?

Chest·2026
Same author

Artificial intelligence in heart failure - a comprehensive literature review.

Cardiology journal·2025
Same author

When the ECG Deceives: A Case of Pseudo-Wellens' Syndrome in the Setting of Stress-Induced Cardiomyopathy.

Journal of investigative medicine high impact case reports·2025
Same author

Respiratory physiological changes in pregnancy.

Respiratory medicine·2025
Same author

Efficacy and safety of empagliflozin in acute heart failure: a systematic review and meta-analysis.

Future cardiology·2025

Related Experiment Video

Updated: Nov 18, 2025

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
04:45

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Published on: June 2, 2022

2.6K

Naloxone induced pulmonary edema.

Sherif Elkattawy1, Ramez Alyacoub1, Chidinma Ejikeme1

  • 1Department of Internal Medicine, Rutgers New Jersey Medical School/Trinitas Regional Medical Center Program, Elizabeth, NJ, USA.

Journal of Community Hospital Internal Medicine Perspectives
|February 8, 2021
PubMed
Summary

Naloxone can rarely cause noncardiogenic pulmonary edema after opioid overdose reversal, especially with higher doses. Early treatment with diuretics and oxygen improved patient outcomes without mechanical ventilation.

Area of Science:

  • Emergency Medicine
  • Toxicology
  • Pulmonology

Background:

  • Opioid overdose reversal with naloxone can rarely lead to noncardiogenic pulmonary edema.
Keywords:
Naloxoneopioidspulmonary edema

More Related Videos

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome
06:06

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome

Published on: October 26, 2018

10.1K
Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
14:52

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Published on: January 13, 2018

11.2K

Related Experiment Videos

Last Updated: Nov 18, 2025

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
04:45

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Published on: June 2, 2022

2.6K
Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome
06:06

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome

Published on: October 26, 2018

10.1K
Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
14:52

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Published on: January 13, 2018

11.2K
  • This rare adverse effect is thought to be due to an adrenergic crisis causing fluid shifts into the pulmonary vasculature.
  • Higher doses of naloxone may increase the risk of developing this complication.